STAT

STAT

Share

STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We dissect crucial discoveries.

We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

Do wearables actually help people with cardiovascular disease? 06/18/2026

In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.

Do wearables actually help people with cardiovascular disease? In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.

CMS recalculates Medicare Advantage star ratings again, adding more volatility to program 06/18/2026

Medicare Advantage plans that receive four out of five stars or better get bonus payments, which have ballooned to $16 billion this year.

CMS recalculates Medicare Advantage star ratings again, adding more volatility to program Medicare Advantage plans that receive four out of five stars or better get bonus payments, which have ballooned to $16 billion this year.

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy 06/18/2026

A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.

Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data 06/18/2026

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.

Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.

Shingles vaccine may lower dementia risk, new study finds 06/18/2026

Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.

Shingles vaccine may lower dementia risk, new study finds Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.

Six of the biggest health news stories today 06/18/2026

High-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Rounds

Six of the biggest health news stories today High-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Rounds

Super-potent synthetic opioids called nitazenes are spreading across the U.S. 06/18/2026

Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC

Super-potent synthetic opioids called nitazenes are spreading across the U.S. Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC

Cambrian's experimental longevity drug mimics exercise 06/18/2026

What Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The Readout

Cambrian's experimental longevity drug mimics exercise What Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The Readout

Pharmalittle: We're reading about an FDA review of Moderna's flu shot, J&J's focus on cancer, and more 06/18/2026

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer

Pharmalittle: We're reading about an FDA review of Moderna's flu shot, J&J's focus on cancer, and more Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer

AI’s growing appetite for power is a public health issue. Here’s a fix 06/18/2026

“AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J. Kissinger.

AI’s growing appetite for power is a public health issue. Here’s a fix “AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J. Kissinger.

Want your business to be the top-listed Media Company in Boston?
Click here to claim your Sponsored Listing.

Address


1 Exchange Place
Boston, MA
02120

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm